Biostem Technologies Inc Cash Flow Statement

BSEM $1.49 0.0 0.0%

25/02/21

Speculative, Micro Cap,

Market Cap £9.80m

Enterprise Value £10.6m

Revenue £164k

Quality

Value

Momentum

StockRank™

To unlock Biostem Technologies Inc's cashflow statement please upgrade your membership.

	2010	2011	2012	2015	2016	2017
Period End:	2010-12-31	2011-12-31	2012-12-31	2015-12-31	2016-12-31	2017-12-31
Period Length:	12M	12M	12M	12M	12M	12M
Currency:	USD	USD	USD	USD	USD	USD

Net Income/Starting Line

Depreciation/Depletion
Amortization
Non-Cash Items
Unusual Items
Other Non-Cash Items
Changes in Working Capital
Accounts Receivable
Inventories
Prepaid Expenses
Accounts Payable
Payable/Accrued
Other Liabilities
Cash from Operating Activities

Capital Expenditures
Purchase of Fixed Assets
Purchase/Acquisition of Intangibles
Other Investing Cash Flow Items, Total
Other Investing Cash Flow
Cash from Investing Activities

Financing Cash Flow Items
Other Financing Cash Flow
Issuance (Retirement) of Stock, Net
Issuance (Retirement) of Debt, Net
Cash from Financing Activities

Foreign Exchange Effects
Net Change in Cash
Starting Cash Balance
Ending Cash Balance

Unlock Stockopedia Premium for free!

See what it can do for your stockpicking and portfolio at no expense.